Picard Medical CEO joins AZBio board of directors

Picard Medical Inc. (NYSE American: PMI) announced that Chief Executive Officer Patrick NJ Schnegelsberg has been elected to the Board of Directors of the Arizona Bioindustry Association (AZBio). His term will extend through December 2028.

AZBio serves as the state affiliate in Arizona of the Biotechnology Industry Organization, the national association for biotechnology companies. The organization promotes the growth of Arizona bioscience companies and acts as the unified voice of the bioscience industry in the state.

"Arizona has long been an important hub for life sciences innovation, and AZBio plays a critical role in fostering collaboration and growth across our industry," Schnegelsberg stated in the announcement. "SynCardia has deep roots in Arizona, and I am honored to join the AZBio Board to help strengthen the states bioscience ecosystem and advance lifesaving medical technologies for patients."

Joan Koerber-Walker, President and CEO of AZBio, commented on the appointment: "For over two decades, SynCardia has been at the heart of Arizona's MedTech sector, driving innovation, creating opportunity, and saving lives."

Picard Medical is the parent company of SynCardia Systems LLC, which is based in Tucson and develops the SynCardia Total Artificial Heart. The device is approved by both the U.S. Food and Drug Administration and Health Canada. According to the company, more than 2,100 implants have been performed at hospitals across 27 countries.

The information was disclosed in a company press release.

You May Also Be Interested In

• Greenland Energy adds Carol Craig to board of directors
• Diana Shipping urges Genco shareholders to vote against poison pill
• Diana Shipping urges Genco shareholders to vote against poison pill